e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Mainz Biomed N.V. - Ordinary Shares
(NQ:
MYNZ
)
1.410
-0.070 (-4.73%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 16, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
126,342
Open
1.480
Bid (Size)
1.380 (10)
Ask (Size)
1.470 (5)
Prev. Close
1.480
Today's Range
1.400 - 1.504
52wk Range
0.1800 - 8.200
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Mainz Biomed to Attend 2025 Maxim Growth Summit
October 15, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed Reports Topline Results from Feasibility Study of Biomarker Panel in Pancreatic Cancer Project
October 08, 2025
Study Demonstrated a Sensitivity of 100% and Specificity of 95%
From
Mainz BioMed NV
Via
GlobeNewswire
Performance
YTD
-67.2%
-67.2%
1 Month
-13.0%
-13.0%
3 Month
-23.4%
-23.4%
6 Month
-56.2%
-56.2%
1 Year
+343.4%
+343.4%
More News
Read More
Mainz Biomed to Present the Future of Colorectal Cancer Screening at WEO CRC Screening Committee Meeting
September 30, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed Announces Commercial Launch of ColoAlert® in Switzerland
September 23, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed Announces Registration of ColoAlert in the United Kingdom
September 02, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed Receives Swiss Regulatory Approval to Market ColoAlert®
August 13, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed Announces Pricing of $3.0 Million Follow-On Offering of Ordinary Shares and Warrants
August 04, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
August 01, 2025
Via
Benzinga
Mainz Biomed and CARE Conclude Cooperation Agreement for Joint Care Concept for Health Insurance Companies
July 23, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 16, 2025
Via
Benzinga
Mainz Biomed Half Year 2025 Update: Accelerating FDA Pathway for NextGen Colorectal Cancer Screening and Expansion with Pancreatic Cancer Screening Acquisition
July 15, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test
June 25, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project
June 10, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed Announces Pricing of $4.0 Million Follow-On Offering of Ordinary Shares and Warrants
May 19, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
These stocks are moving in today's pre-market session
May 19, 2025
Via
Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 19, 2025
Via
Benzinga
Why Novavax Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
May 19, 2025
Via
Benzinga
Mainz Biomed Announces Interim Read Out For Its eAArly DETECT 2 Clinical Study
May 16, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed Enters into Technology Partnership with EDX Medical Group
April 29, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval
April 28, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 08, 2025
Via
Benzinga
Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update
April 01, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study
March 27, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer
March 13, 2025
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed Vs. Aurinia Pharma: Retail Traders Weigh In On The Better Biotech Bet
March 07, 2025
Via
Stocktwits
Frequently Asked Questions
Is Mainz Biomed N.V. - Ordinary Shares publicly traded?
Yes, Mainz Biomed N.V. - Ordinary Shares is publicly traded.
What exchange does Mainz Biomed N.V. - Ordinary Shares trade on?
Mainz Biomed N.V. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Mainz Biomed N.V. - Ordinary Shares?
The ticker symbol for Mainz Biomed N.V. - Ordinary Shares is MYNZ on the Nasdaq Stock Market
What is the current price of Mainz Biomed N.V. - Ordinary Shares?
The current price of Mainz Biomed N.V. - Ordinary Shares is 1.410
When was Mainz Biomed N.V. - Ordinary Shares last traded?
The last trade of Mainz Biomed N.V. - Ordinary Shares was at 10/16/25 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.